Literature DB >> 20197689

Undercarboxylated osteocalcin is a biomarker of carotid calcification in patients with essential hypertension.

Takafumi Okura1, Mie Kurata, Daijiro Enomoto, Masanori Jotoku, Tomoaki Nagao, Veena Rasika Desilva, Jun Irita, Ken-Ichi Miyoshi, Jitsuo Higaki.   

Abstract

The development of vascular calcification is an active, highly regulated process with similarities to bone formation. Osteocalcin (OC), a vitamin K-dependent protein expressed by osteoblasts, contains 3 gamma-carboxyglutamic acid residues derived from the vitamin K-dependent posttranslational modification of glutamic acid residues. Circulating undercarboxylated OC (ucOC) is increased in vitamin K deficiency and serum ucOC is reported to be a clinical marker of vitamin K status. Vitamin K deficiency is associated with vascular calcification as well as osteoporosis. We evaluated the relationship between ucOC and carotid artery calcification in 92 patients with essential hypertension. Ultrasound of the common carotid artery was performed to identify vascular calcification and subjects were divided into 2 groups: a calcification (+) group and a calcification (-) group. Serum creatinine and ucOC levels were higher in the calcification (+) group than in the calcification (-) group and serum ucOC correlated with serum creatinine. To identify the independent determinant factor for carotid artery calcification, we applied both ucOC and estimated glomerular filtration rate as independent factors in logistic regression analysis. Serum ucOC was an independent determinant of carotid calcification, suggesting that circulating ucOC may be an important biomarker of carotid artery calcification. Copyright 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197689     DOI: 10.1159/000289575

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  12 in total

Review 1.  Osteocalcin: a pivotal mediator or an innocent bystander in energy metabolism?

Authors:  Mohammed Shawkat Razzaque
Journal:  Nephrol Dial Transplant       Date:  2010-12-03       Impact factor: 5.992

2.  Reconsider hypertension phenotypes and osteoporosis.

Authors:  Charalampos Dokos; Christos Savopoulos; Apostolos Hatzitolios
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-12-17       Impact factor: 3.738

Review 3.  Serum biomarkers for arterial calcification in humans: A systematic review.

Authors:  Nienke M S Golüke; Marit A Schoffelmeer; Annemarieke De Jonghe; Mariëlle H Emmelot-Vonk; Pim A De Jong; Huiberdina L Koek
Journal:  Bone Rep       Date:  2022-06-18

4.  Osteoprotegerin is a Better Serum Biomarker of Coronary Artery Calcification than Osteocalcin in Type 2 Diabetes.

Authors:  Raelene E Maser; M James Lenhard; Michael B Sneider; Ryan T Pohlig
Journal:  Endocr Pract       Date:  2015-01       Impact factor: 3.443

5.  Serum levels of undercarboxylated osteocalcin are related to cardiovascular risk factors in patients with type 2 diabetes mellitus and healthy subjects.

Authors:  Sergio Sanchez-Enriquez; Isabel Thalia Ballesteros-Gonzalez; José Rafael Villafán-Bernal; Sara Pascoe-Gonzalez; Edgar Alfonso Rivera-Leon; Blanca Estela Bastidas-Ramirez; Jorge David Rivas-Carrillo; Juan Luis Alcala-Zermeno; Juan Armendariz-Borunda; Iris Monserrat Llamas-Covarrubias; Abraham Zepeda-Moreno
Journal:  World J Diabetes       Date:  2017-01-15

6.  Osteocalcin, Vascular Calcification, and Atherosclerosis: A Systematic Review and Meta-analysis.

Authors:  Sophie A Millar; Hinal Patel; Susan I Anderson; Timothy J England; Saoirse E O'Sullivan
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

7.  Plasma phylloquinone, menaquinone-4 and menaquinone-7 levels and coronary artery calcification.

Authors:  S Torii; Y Ikari; K Tanabe; T Kakuta; M Hatori; A Shioi; T Okano
Journal:  J Nutr Sci       Date:  2016-12-29

8.  Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease.

Authors:  Minfang Zhang; Zhaohui Ni; Wenyan Zhou; Jiaqi Qian
Journal:  J Biomed Sci       Date:  2015-09-17       Impact factor: 8.410

9.  Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis.

Authors:  Sayaka Namba; Minako Yamaoka-Tojo; Takehiro Hashikata; Yuki Ikeda; Lisa Kitasato; Takuya Hashimoto; Takao Shimohama; Taiki Tojo; Naonobu Takahira; Takashi Masuda; Junya Ako
Journal:  BBA Clin       Date:  2015-08-12

Review 10.  New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs).

Authors:  Rick H van Gorp; Leon J Schurgers
Journal:  Nutrients       Date:  2015-11-17       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.